Mizuho Securities analyst Anthony Petrone maintains $Intuitive Surgical (ISRG.US)$ with a hold rating, and adjusts the target price from $500 to $550.
According to TipRanks data, the analyst has a success rate of 51.4% and a total average return of 8.4% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Intuitive Surgical (ISRG.US)$'s main analysts recently are as follows:
Intuitive Surgical's Q3 earnings surpassed expectations, signaling a robust quarter propelled by significant placements of the Da Vinci 5 system, a strong increase in procedure volumes, and sustained margin discipline. Additionally, the company has elevated its FY24 procedure volume growth forecast to a range of 16%-17%, taking into account the potential for continued challenges in bariatric procedures and the impact of ongoing physician strikes in Korea, as well as the current state of affairs in China.
The sentiment that the market may be anticipating a substantial revenue outperformance for FY25 was expressed, particularly after the company's earnings report led to an approximate 3% increase in FY25 EPS estimates.
Intuitive Surgical exhibited 'strong' results for Q3, surpassing expectations in the two most crucial metrics - DV5 placements and procedure growth. Following the U.S. approval of the da Vinci 5, the company has quickly gained significant growth momentum. The early adoption of DV5 is progressing faster than the launch of the fourth-generation system, with promising indications of further growth acceleration as we approach 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
瑞穗證券分析師Anthony Petrone維持$直覺外科公司 (ISRG.US)$持有評級，並將目標價從500美元上調至550美元。
根據TipRanks數據顯示，該分析師近一年總勝率為51.4%，總平均回報率為8.4%。
此外，綜合報道，$直覺外科公司 (ISRG.US)$近期主要分析師觀點如下：
直覺外科公司的第三季度收益超出預期，表明一個強勁的季度受益於達芬奇5系統的重大安置、手術量的大幅增長和持續的利潤率紀律。此外，該公司已經將其FY24手術量增長預測提升至16%-17%的區間，考慮到在減肥手術領域持續面臨挑戰以及韓國醫生罷工和中國局勢的影響。
市場可能預期FY25年營業收入表現出色的情緒表達出來，特別是在公司發佈的收益報告後，導致FY25年每股收益預期約增加3%。
直覺外科公司展示了第三季度的「強勁」成果，超出了兩個最關鍵指標的預期——DV5的安置量和手術增長。在達芬奇5獲得美國批准後，公司迅速獲得了顯著的增長動力。DV5的早期採用速度比第四代系統的推出速度更快，很有希望在接近2025年時出現進一步的增長加速跡象。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
